Laboratory-developed tests final rule: public health benefits outweigh the costs

The clinical laboratory industry has loudly protested the Food and Drug Administration's final rule to oversee laboratory-developed tests, claiming the costs do not justify the benefits. FDA's economic impact analysis of the rule suggests otherwise.

Download our fact sheet to discover how much the public stands to benefit from this rule.